$SG

Sweetgreen Stumbles Again. Are the Turnaround Chances Gone?

Sweetgreen (NYSE: SG) reported another weak quarter after hours, with shares down double digits before partially recovering. Same-store sales decline narrowed to 6.2% in Q2 from 12.8% in Q1, but a cyclospora outbreak hurt July comps, cutting full-year guidance to same-store sales down 7%-8% and adjusted EBITDA loss of $23M-$27M. Management cited improving throughput and wrap adoption.

Original reporting
Published Aug 8, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 12:13 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sweetgreen Stumbles Again. Are the Turnaround Chances Gone? — source image
Decision brief

The 30-second read

$SGBearishMed
01

Why it matters

The cyclospora outbreak created a demand shock that forced management to materially widen the expected decline in same-store sales and move adjusted EBITDA to a loss, while also stating recovery timing is uncertain.

02

Market read

Traders should focus on the magnitude of the guidance reset and the stated uncertainty around recovery timing, since it directly affects forward estimates and risk premium for the turnaround.

03

What to watch

The article notes iceberg lettuce is not used and products were not directly affected, implying the demand hit could mean-revert faster than the market assumes once consumer fears subside.

Relevance 8/10Novelty 6/10Timing: after-hours earnings report, with stock down double digits Friday morning

Background

Sweetgreen is in an ongoing turnaround, with prior declines in same-store sales and a strategy shift toward wraps, pricing changes, and throughput improvements.

Company-level read

Ticker impact

$SGBearishMedium confidence
Context

Sweetgreen reported another disappointing earnings result and cut full-year same-store sales guidance to down 7%-8% after a cyclospora outbreak hit comps.

Expected impact

Bearish near term, with potential for stabilization only if early-July-style positive comps return after the outbreak fades.

Evidence & confidence

The article cites a concrete guidance cut (comps and adjusted EBITDA) tied to the cyclospora-driven demand shock, which typically pressures valuation until visibility improves.

Market effects

Highlights fast-casual demand sensitivity to food-safety scares and the importance of throughput and value perception in sustaining comps.

No specific regional market impact beyond mention of New York and Seattle wrap adoption.

Limited, as the shock appears localized to consumer behavior around the outbreak rather than a global supply disruption.

Counterpoint

Operational metrics (throughput improvements, wrap adoption, pricing changes) suggest the business model is adjusting, so the guidance cut may be temporary if demand normalizes.

Key entities

  • Sweetgreen

    Fast-casual restaurant chain whose earnings and full-year guidance were cut due to cyclospora-related consumer fear.

  • cyclospora outbreak

    Food-safety outbreak that management links to a July comparable sales deterioration and guidance reset.

Related articles

$SGHighAI 9/10

Sweetgreen (SG) Q2 2026 Earnings Call Transcript

Sweetgreen (SG) reported Q2 2026 revenue of $192.7M, up 4% YoY, driven by 36 net new restaurant openings. Same-store sales fell 6.2%. Restaurant-level margin was 13.1% and adjusted EBITDA was a $0.2M loss. FY2026 guidance was revised for cyclospora impacts, with comparable sales expected to decline 7% to 8% and restaurant margin 10.5% to 11.0%.

$SGHighAI 8/10

Sweetgreen Says Wraps Are a Hit With Diners, But Cyclospora Scare Clouds Outlook — BigGo Finance

Sweetgreen Inc. (NYSE:SG) said its lower-priced wraps are driving loyalty and transactions, with CEO Jonathan Neman citing about a 20% incidence rate since the national launch and a 30-day return rate above the Harvest Bowl. Cyclospora-related negative headlines in mid-July led the company to cut full-year 2026 guidance. Q2 revenue was $192.7M (+4% YoY), but comparable sales fell 6.2% and restaurant margin dropped to 13.1%.

$SGHighAI 8/10

After a Wraps Win, Sweetgreen Faces a Fresh Setback

Sweetgreen introduced lower-priced wraps after a weak Q1 to improve value perception and drive repeat visits. Wraps reached about a 20% incidence rate and improved retention, but same-store sales fell 6.2% in Q2. Revenue rose ~4% to $192.7M. A cyclospora-related demand hit led to a lowered full-year outlook and guidance.

$SGMed

Parasite Outbreak Fears Crush Restaurant Sales Weeks After RFK Jr. Said It Was “Under Control”

On July 21, HHS Secretary Robert F. Kennedy Jr. said the multistate cyclosporiasis outbreak tied to iceberg lettuce was “under control.” By Aug. 5, the CDC reported 6,358 illnesses in 15 states, 278+ hospitalizations, and two deaths. The FDA linked the recall to Taylor Farms, and restaurant chains including Sweetgreen (SG) and Salad and Go filed for Chapter 11, citing outbreak-related demand impacts.

$SGHighAI 9/10

Sweetgreen Q2 Earnings Call Highlights

Sweetgreen (NYSE:SG) reported Q2 comparable transaction declines narrowing from -11.2% in Q1 to about -3% in April-May and near flat in June. Restaurant-level profit was $25.2M (13.1% margin) and adjusted EBITDA was a $0.2M loss. Wraps drove frequency but lower check weighed mix. Sweetgreen cut 2026 outlook for disruption, expecting comps -8% to -7% and adjusted EBITDA loss of $27M to $23M.

$SGHighAI 9/10

Sweetgreen Shares Slide After Weak Second-Quarter Results and Lower Outlook

Sweetgreen (NYSE:SG) shares fell about 15% premarket after it reported Q2 2026 results that missed expectations. Revenue rose 3.8% to $192.7M, but GAAP loss widened to $0.22 per share. Comparable sales fell 6.2% and restaurant margin dropped to 13.1% from 18.9%. Sweetgreen cut full-year EBITDA guidance to about -$25M at midpoint, citing a cyclospora outbreak.